Key facts
- ARC Ento Tech’s last known valuation is $20.0M (Dec 2024).
- It has raised $6.3M; the latest was Early Stage VC ($5.0M) in Dec 2024.
- Notable investors include Catallyze, MCCi.
- Status: Privately Held (backing).
- ·The complete investor list — 2 names
- ·Watchlist + deal alerts for ARC Ento Tech
- ·The full record, as it builds
Funding rounds
No funding rounds for ARC Ento Tech are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About ARC Ento Tech
Operator of a waste management company intended to tackle solid and agricultural waste processing problems. The company specializes in offering a wide range of products, such as soil biochar, black soldier fly larvae, soil insect frass, and services such as remediation and amelioration, poultry waste management, and waste segregation, enabling clients to reduce environmental impact, landfill issues, and greenhouse gas emissions.
- Sector
- Business Products and Services (B2B)
- HQ
- Somersby, Australia
- Founded
- 2020
- Website
- arcentotechltd.com.au/
- Ownership
- Privately Held (backing)
ARC Ento Tech doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in ARC Ento Tech shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on ARC Ento Tech in its N-PORT filings yet. We sweep new filings monthly.